Transmission and immunopathogenesis of FIV in cats as a model for HIV

被引:103
作者
Burkhard, MJ [1 ]
Dean, GA [1 ]
机构
[1] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA
关键词
FIV; immunopathogenesis; HIV animal model; mucosal transmission; feline; FELINE IMMUNODEFICIENCY VIRUS; CHEMOKINE RECEPTOR CXCR4; LONG TERMINAL REPEAT; AP-1; BINDING-SITE; BLOOD MONONUCLEAR-CELLS; POLYMERASE-CHAIN-REACTION; CYTOTOXIC T-LYMPHOCYTES; IN-VIVO REPLICATION; FREE-RANGING LIONS; PRODUCTIVE INFECTION;
D O I
10.2174/1570162033352101
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The feline immunodeficiency virus (FIV) model provides a system to study lentivirus transmission, virus kinetics, pathogenesis, host responses, and immune dysfunction in a natural, out-bred host, under controlled conditions with specific-pathogen-free animals. The diversity of primary FIV strains can be exploited to mirror the range of disease manifestations associated with HIV infection. FIV is infectious via intravenous, intraperitoneal, intradermal, or subcutaneous injection as well as by atraumatic instillation onto the oral, vaginal, or rectal mucosa. Together, these features allow investigators to model specific aspects of HIV infection in a highly relevant and relatively inexpensive animal model. Well-developed areas of the FIV model include: (1) transmission of cell-associated as well as cell-free virus; (2) mucosal infectivity and immunopathogenesis; (3) vertical transmission; (4) acquired immunodeficiency including defects of the innate immune system; (5) thymic dysfunction; (6) neurotropism and neuropathogenesis; (7) host-virus interactions and the role of specific gene products; (8) efficacy of antiviral therapy; and (9) efficacy and immune correlates of experimental vaccines. This review will encompass areas specific to transmission and immunopathogenesis.
引用
收藏
页码:15 / 29
页数:15
相关论文
共 256 条
[31]  
Burkhard MJ, 1997, VACCINE, V15, P107, DOI 10.1016/S0264-410X(96)00182-X
[32]   Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route [J].
Burkhard, MJ ;
Mathiason, CK ;
O'Halloran, K ;
Hoover, EA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (03) :217-226
[33]   Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection [J].
Burkhard, MJ ;
Mathiason, CK ;
Bowdre, T ;
Hoover, EA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (18) :1767-1778
[34]   Distribution of immune cells in the female reproductive tract in uninfected and FIV infected cats [J].
Butterworth, JL ;
English, RV ;
Jordan, HL ;
Tompkins, MB .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2001, 83 (1-2) :37-51
[35]  
BUTTERWORTH JL, 1997, EFFECT FELINE IMMUNO
[36]  
CALLANAN JJ, 1994, ADV EXP MED BIOL, V355, P169
[37]   Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections [J].
Callanan, JJ ;
Jones, BA ;
Irvine, J ;
Willett, BJ ;
McCandlish, IAP ;
Jarrett, O .
VETERINARY PATHOLOGY, 1996, 33 (03) :264-272
[38]   TRANSMISSION OF FELINE IMMUNODEFICIENCY VIRUS FROM MOTHER TO KITTEN [J].
CALLANAN, JJ ;
HOSIE, MJ ;
JARRETT, O .
VETERINARY RECORD, 1991, 128 (14) :332-333
[39]   Genetic and phylogenetic divergence of feline immunodeficiency virus in the puma (Puma concolor) [J].
Carpenter, MA ;
Brown, EW ;
Culver, M ;
Johnson, WE ;
PeconSlattery, J ;
Brousset, D ;
OBrien, SJ .
JOURNAL OF VIROLOGY, 1996, 70 (10) :6682-6693
[40]   Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat [J].
Carpenter, MA ;
Brown, EW ;
MacDonald, DW ;
O'Brien, SJ .
VIROLOGY, 1998, 251 (02) :234-243